Calculate your SIP Return

Open Demat Account

Open Demat Account Login

₹0 Free Equity Delivery
₹20/- For Intraday, F&O, Currencies & Commodities

Tarsons Products IPO

Incorporated in 1983, Tarsons Products Ltd. is one of the leading life sciences companies involved in the manufacturing and supplying of labware products. The company comes with a highly diversified product portfolio, including lab consumables, reusable products and more.

Products manufactured in Tarsons are widely used across hospitals, diagnostic labs, academic institutions, pharmaceutical companies and more.

Tarsons Products currently has 5 manufacturing facilities in West Bengal, sprawling over 20,000 square metres. As of 31 March 2021, the company has a product portfolio with more than 1,700 SKUs for 300 products.

The company has a robust distribution network throughout India, with more than 141 authorised distributors. Moreover, it supplies its products to more than 40 countries.

Tarsons Products IPO: Objectives

Tarsons Products intends to use the proceeds from its public offering for the following purposes:

To fund a portion of the capital expenditure that is required for the expansion of its facility in Panchla, West Bengal
To either repay or prepay its borrowings
For general corporate expenses

Tarsons Products IPO - Details

Tarsons Products filed its DRHP with market regulator SEBI for its IPO on 10 August 2021. The initial public offering of Tarsons Products will include a fresh issuance of shares worth Rs. 150 crores and an offer for sale of 1.32 crores shares by the existing investors and promoters.

The offer for sale will include the offloading of 3.9 lakhs shares by Sanjive Sehgal, and 3.1 lakhs share sale by Rohan Sehgal. Apart from this, Clear Vision Investment Holdings Pvt. Ltd. is set to release around 1.25 crores shares. Tarsons Products IPO will also include a reservation for company employees.

The key details of Tarsons Products IPO are shown in the following tabular representation:

Opening Date

Nov 15, 2021

Closing Date

Nov 17, 2021

Price Band

₹635 to ₹662

per equity share

Issue Size

₹1,023.47 Cr

Face Value

₹ 2

per equity share

Market Lot

22 Shares

Opening Date

Sep 14, 2021

Closing Date

Sep 16, 2021

Price Band

₹734 to ₹744

per equity share

Issue Size

₹1265 - ₹1283 Cr

Face Value

₹ 2

per equity share

Market Lot

20 Shares

Listing at NSE, BSE

Tarsons Products IPO Important Dates

IPO Open Date	15 November 2021
IPO Close Date	17 November 2021
Date for Basis of Allotment	23 November 2021
Initiation Of Refunds	24 November 2021
Credit Of Shares To Demat ACcount	26 November 2021

Tarsons Products IPO Latest News and Subscription Status Today [Live]

Day 3: 17th Nov. 2021
Day 2: 16th Nov. 2021
Day 1: 15th Nov. 2021

At 10.40:00 AM.

- This IPO has been subscribed 4.18x by 10:40 AM. on Day 3

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 1.30x

- (NII) Non-institutional buyers: 4.69x

- (RII) Retail Individual buyers: 5.63x

-Employees: 1.15x

At 11.40:00 AM.

- This IPO has been subscribed 4.80x by 11:40 AM. on Day 3

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 1.32x

- (NII) Non-institutional buyers: 5.58x

- (RII) Retail Individual buyers: 6.50x

-Employees: 1.21x

At 12.40:00 PM.

- This IPO has been subscribed 8.06x by 12:40 PM. on Day 3

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 1.49x

- (NII) Non-institutional buyers: 19.07x

- (RII) Retail Individual buyers: 7.17x

-Employees: 1.27x

At 10.40:00 AM.

- This IPO has been subscribed 1.38x by 10:40 AM. on Day 2

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.21x

- (RII) Retail Individual buyers: 2.69x

- Employees: 0.48x

At 11.40:00 AM.

- This IPO has been subscribed 1.53x by 11:40 AM. on Day 2

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.21x

- (RII) Retail Individual buyers: 2.95x

- Employees: 0.64x

At 12.40:00 PM.

- This IPO has been subscribed 1.66x by 12:40 PM. on Day 2

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.21x

- (RII) Retail Individual buyers: 3.23x

- Employees: 0.65x

At 1.40:00 PM.

- This IPO has been subscribed 1.77x by 1:40 PM. on Day 2

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.28x

- (RII) Retail Individual buyers: 3.42x

- Employees: 0.67x

At 2.40:00 PM.

- This IPO has been subscribed 2.08x by 2:40 PM. on Day 2

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 0.24x

- (NII) Non-institutional buyers: 0.38x

- (RII) Retail Individual buyers: 3.87x

- Employees: 0.90x

At 3.40:00 PM.

- This IPO has been subscribed 3.18x by 3:40 PM. on Day 2

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 1.10x

- (NII) Non-institutional buyers: 3.69x

- (RII) Retail Individual buyers: 4.18x

- Employees: 0.90x

At 5.05:00 PM.

- This IPO has been subscribed 3.58x by 5:05 PM. on Day 2

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 1.30x

- (NII) Non-institutional buyers: 3.98x

- (RII) Retail Individual buyers: 4.74x

- Employees: 1.08x

At 11.00:00 AM.

- This IPO has been subscribed 0.33x by 11:00 AM. on Day 1

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.01x

- (RII) Retail Individual buyers: 0.67x

- Employees: 0.00x

At 12.05:00 PM.

- This IPO has been subscribed 0.48x by 12:05 PM. on Day 1

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.01x

- (RII) Retail Individual buyers: 0.96x

- Employees: 0.04x

At 1.05:00 PM.

- This IPO has been subscribed 0.60x by 1:05 PM. on Day 1

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.05x

- (RII) Retail Individual buyers: 1.18x

- Employees: 0.07x

At 2.05:00 PM.

- This IPO has been subscribed 0.71x by 2:05 PM. on Day 1

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.06x

- (RII) Retail Individual buyers: 0.15x

- Employees: 0.07x

At 3.05:00 PM.

- This IPO has been subscribed 0.84x by 3:05 PM. on Day 1

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.09x

- (RII) Retail Individual buyers: 1.65x

- Employees: 0.19x

At 4.05:00 PM.

- This IPO has been subscribed 0.93x by 4:05 PM. on Day 1

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.10x

- (RII) Retail Individual buyers: 1.82x

- Employees: 0.29x

At 5.05:00 PM.

- This IPO has been subscribed 1.09x by 5:05 PM. on Day 1

- It is a public issue of 1,08,44,104 equity shares.

Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.17x

- (RII) Retail Individual buyers: 2.12x

- Employees: 0.41x

Why Should You Invest in Tarsons Products IPO?

Here are some of the key reasons why Tarsons Products is an ideal investment option: –

Tarsons Products is one of the top life sciences companies engaged in manufacturing a wide range of lab components. The company is known for its high-quality goods and excellent brand awareness.
The company comes with a massive client base, including some of the reputed Indian institutions such as Dr. Reddy’s Laboratories, Indian Institute of Chemical Technology, Metropolis Healthcare, Dr. Lal Path Labs, Enzene Biosciences, National Centre for Biological Sciences, and more.
Tarsons Products has a robust sales and distribution network across the country. It also supplies its products to major international markets.
The company comes with impressive financials with strong assets, revenue generation and profit.

Financial Highlights

Financial Year	Total Assets	Total Revenue	Profit After Tax
30 June 2021	Rs. 3,647.74	Rs. 711.27	Rs. 248.35
31 March 2021	Rs. 2,959.50	Rs. 2,342.91	Rs. 688.70
30 June 2020	Rs. 2,356.57	Rs. 435.73	Rs. 69.68
31 March 2020	Rs. 2,487.06	Rs. 1,800.54	Rs. 405.31
31 March 2019	Rs. 2,119.58	Rs. 1,847.19	Rs. 389.58

**Note: Amount is in millions

How to Apply for Tarsons Products IPO?

You can apply for the Tarsons Products IPO in these ways:

Demat Account

1. The existing users of the Angel One platform can click here to apply for Tarsons Products IPO.
2. However, new investors can open a Demat account free of cost on the Angel One platform. Then, investors can log in with the credentials that they receive to start bidding for Tarsons Products IPO.

UPI
Alternatively, you can apply for Tarsons Products IPO through UPI. First, you need to connect your bank account with a preferred UPI platform. Then, link it with your Angel One account. After that, you can use the UPI option present on the Angel One website and app to subscribe to Tarsons Products IPO.
Finally, go to the UPI app to book shares for the IPO.

Tarsons Products IPO – Noteworthy Highlights

The following section consists of some crucial highlights about Tarsons Products that prospective investors should be aware of:

1. The company boasts of having 5 well-equipped manufacturing facilities that are vertically integrated and come with automation facilities. This helps the company to maintain quality while cutting costs.

2. For the financial year ending on 31 March 2021, Tarsons Products registered a 23.67% growth in its net worth along with a 49.36% jump in EBITDA.

3. The total asset of Tarsons Products climbed by 19% during the last financial year.

4. Some of its products, such as cryovials, macro tips, micro tips, and centrifuge tubes, have received CE-IVD certification.

5. The company exports its lab products to more than 40 countries.

6. Tarsons Products come with operating revenue that ranges between Rs. 100-Rs. 500 crores for the financial year that ended on 31 March 2021.

Tarsons Products IPO - SWOT Analysis

strengths

Strengths

Diverse product portfolio: Tarsons Products manufactures and supplies a diverse range of labware components which are broadly classified into consumables, reusable and other products.

The consumable product section includes cryogenic ware, petri dish, PCR consumables transfer pipettes and more. In the reusable segments, the company manufactures bottles, beakers, carboys and more. It also produces vortex shakers, centrifuges and other benchtop instruments. These products are supplied to numerous reputed hospitals, diagnostic centres and national institutions.
Addresses a Large Market: The labware market is witnessing massive growth in India fueled by increased investment, growing awareness for health issues, and enormous growth in the health sector. Tarsons addresses a major domestic and international market and maintains long-term connections with its customers and clients.
Strong Management Team: Founded in 1983, Tarsons Products is backed by highly experienced promoters and a powerful management team. This has enabled the company to bolster its presence in the Indian labware market.
Strong Financial Performance: Tarsons has been able to post improved financial performance due to cost-cutting and higher profitability. The company's revenue and profit have been on a steady rise for the past three years. Its long-term and current borrowings have also come down recently.

Weaknesses

Weaknesses

Cost Overrun or Implementation Delay: The company has five facilities and is planning to build another one. Moreover, it would be working on expanding all the existing facilities. Considering the capacity of the expansion plan, Tarsons might be facing implementation delays or cost overruns.
Geographical Concentration of Manufacturing Units: All of the manufacturing units of Tarsons Products are located in West Bengal. Around 86.32% of the manufacturing revenue comes from the units located at Dhulagarh and Jangalpur. Such concentration of manufacturing might affect business operations and finances.
Pending Land Approval at one of the Facilities: The manufacturing facility at Jangalpur is situated on a plot for which the company is yet to receive complete approval. Delay in approval might lead to regulatory actions in the future.

Opportunities

Opportunities

Expansion of Client Base: The healthcare sector of the country will see significant growth as investments are set to increase. Consequently, the demand for lab consumables and reusable products would jump, leading to a potential expansion of the labware market. Tarsons already has an impressive list of reputed clients. However, it has the potential to expand its client base with rising demand.

Threats

Threats

Rise in Inflation: Inflation rates have been quite volatile in recent years. If inflation rises in the upcoming days, it will lead to increased expenses and reduced revenue generation. This can adversely impact the business prospects and finances of the company.
Impact of the Pandemic: Although the COVID-19 pandemic has subdued in recent months, the threat still remains. The new virus variants might spark off COVID-19 waves, which can significantly affect the business.

Strenghts

Strengths

Weaknesses

Weaknesses

Opportunities

Opportunities

Threats

Threats

Strengths

Diverse Product Portfolio: Tarsons Products manufactures and supplies a diverse range of labware components which are broadly classified into consumables, reusable and other products.
The consumable product section includes cryogenic ware, petri dish, PCR consumables transfer pipettes and more. In the reusable segments, the company manufactures bottles, beakers, carboys and more. It also produces vortex shakers, centrifuges and other benchtop instruments. These products are supplied to numerous reputed hospitals, diagnostic centres and national institutions.
Addresses a Large Market: The labware market is witnessing massive growth in India fueled by increased investment, growing awareness for health issues, and enormous growth in the health sector. Tarsons addresses a major domestic and international market and maintains long-term connections with its customers and clients.
Strong Management Team: Founded in 1983, Tarsons Products is backed by highly experienced promoters and a powerful management team. This has enabled the company to bolster its presence in the Indian labware market.
Strong Financial Performance: Tarsons has been able to post improved financial performance due to cost-cutting and higher profitability. The company's revenue and profit have been on a steady rise for the past three years. Its long-term and current borrowings have also come down recently.

Weaknesses

Cost Overrun or Implementation Delay: The company has five facilities and is planning to build another one. Moreover, it would be working on expanding all the existing facilities. Considering the capacity of the expansion plan, Tarsons might be facing implementation delays or cost overruns.
Geographical Concentration of Manufacturing Units: All of the manufacturing units of Tarsons Products are located in West Bengal. Around 86.32% of the manufacturing revenue comes from the units located at Dhulagarh and Jangalpur. Such concentration of manufacturing might affect business operations and finances.
Pending Land Approval at one of the Facilities: The manufacturing facility at Jangalpur is situated on a plot for which the company is yet to receive complete approval. Delay in approval might lead to regulatory actions in the future.

Opportunities

Expansion of Client Base: The healthcare sector of the country will see significant growth as investments are set to increase. Consequently, the demand for lab consumables and reusable products would jump, leading to a potential expansion of the labware market. Tarsons already has an impressive list of reputed clients. However, it has the potential to expand its client base with rising demand.

Threats

Rise in Inflation: Inflation rates have been quite volatile in recent years. If inflation rises in the upcoming days, it will lead to increased expenses and reduced revenue generation. This can adversely impact the business prospects and finances of the company.
Impact of the Pandemic: Although the COVID-19 pandemic has subdued in recent months, the threat still remains. The new virus variants might spark off COVID-19 waves, which can significantly affect the business.

Competitor Analysis: Tarsons Products

Tarsons Products is one of the most notable labware manufacturers in the country, with presence in over 40 countries. Here is a brief overview of some of the prominent competitors of Tarsons Products:

Competitor	Revenue
Innova Corporate	$17 million
Acumen Labware	$5 million
BrandTech Scientific Inc.	$5-$9.9 million
PlastX	$5 million
Jensen Inert Products	$1- $4.9 million

Tarsons Products IPO FAQs

How can I apply for Tarsons Products IPO with the Angel One app?

You can apply for an IPO on the Angel One app through these steps:
Step 1: First, open the Angel One app and click on ‘Investment Opportunities'.
Step 2: Now, tap on ‘IPOs and FPOs’ and provide the necessary data.
Step 3: Put the valid UPI ID as authenticated by NPCI.
Step 4: Click on ‘Invest’ to subscribe to Tarsons Products IPO.

I don’t have a UPI ID. Can I apply for Tarsons Products IPO?

If you don’t have a UPI ID, you can use the ASBA process from your bank account to subscribe to Tarsons Products IPO. However, you can easily create a UPI handle from the NPCI list to apply with a UPI ID.

How can I locate my UPI ID?

Go to the ‘Profile’ section of your UPI app to locate your UPI ID. You can click here to check the screenshot for finding the UPI IDs on different apps.

When is the UPI mandate request approved?

The time period within which you will likely receive the approval for your UPI mandate request is from the closing time of the IPO till 12 PM the next day.

How to create a UPI ID with the BHIM app?

Here is a step-by-step guide to creating a UPI ID on the BHIM app:

Step 1: Download the BHIM app.

Step 2: Now, verify the mobile number and then register using a password.

Step 3: Select your bank from the provided list.

Step 4: BHIM app will fetch your bank account details automatically.

Step 5: If you have more than one bank account, choose the one that you want to register with.

Step 6: Set a personal UPI ID.

Once done, you can check your UPI ID from the ‘Profile’ section.

Can I opt for multiple applications for Tarsons Products IPO?

No, you are not allowed to file for one application for one PAN number. Nonetheless, if you try to file for more than one application using the same PAN using different platforms, your applications will be rejected.

How soon can I expect the UPI mandate request after placing an order?

You can expect to receive a UPI mandate request around 15 to 20 minutes after putting in the bid. However, you can face delays at times.

Why am I not able to apply for Tarsons Products IPO through UPI ID?

You have to use NPCI-approved UPI IDs while applying for Tarsons Products IPO. If you are facing any issue with your UPI ID, make sure to check the list of banks that are approved by NPCI to provide UPI services

Can I apply for Tarsons Products IPO if I don’t have my bank account linked with Angel One?

Yes, you can, but the bank account has to be in your name.

Why am I not able to find my UPI handle from the Angel One dropdown menu?

If you cannot find your UPI ID in the dropdown list of the Angel One app, it would imply that NPCI has not approved the ID. Make sure to create a UPI ID with a financial body that is on the list of NCPI.

Do I have to pay a fee to apply for Tarsons Products IPO?

You are not required to pay an additional charge if you apply for Tarsons Products IPO via the Angel One platform.

What is the cut-off price? Can I apply at this price?

Cut-off price is the rate at which the shares for Tarsons Products IPO will be issued. It is fixed during the allotment process, and when one applies at this price, it would mean that they would be bidding at the said price point.
Bidders should apply at the cut-off price to increase their chances of share allotment.

Can I apply for Tarsons Products IPO with a current account?

No. Your application for Tarsons Products IPO will be approved only with a savings account. Make sure to contact your bank to know more about this.

Can I apply for Tarsons Products IPO with my Hindu Undivided Family account?

You cannot apply for the IPO with a HUF account on the Angel One app. However, you can use it to apply through the ASBA process.

The status of the IPO mandate request is pending even after I have the mandate request approved. Why so?

The Angel One UPI mandate request is usually not updated on a real-time basis. In case your mandate is approved, it will be reflected in the order book of the IPO that you have applied for.

Can I apply for Tarsons Products IPO if I reside outside India?

If you are an NRI, you cannot apply for IPOs using the Angel One platform. However, you can subscribe for Indian IPOs through the ASBA of your bank. Make sure to contact your bank for more information.

What can lead to the rejection of my application for Tarsons Products IPO?

Your application for the IPO can be rejected for any of the following reasons:

You have provided an incorrect UPI ID during mandate approval.

The UPI ID, bank account and Demat account are not linked with the same PAN card.

Let’s take an instance to have a clear understanding. If you have used your Demat account along with the UPI ID of your friend while applying for Tarsons Products IPO, the application might get dismissed. This will happen because:

Your Demat account is not linked with your friend’s bank account.

Your PAN card is not connected with your friend’s UPI ID.

How much time is required to block or unblock funds for IPO subscription?

The funds for the Tarsons Products IPO will be blocked once you have approved the UPI mandate request. However, if you are not successful in securing shares during the IPO allotment or if the UPI mandate is no longer valid, then the amount will be unblocked.

If the funds are not unblocked even after the aforementioned scenarios, you can contact your bank.

Can I subscribe to Tarsons Products IPO with my minor daughter’s account?

You are not allowed to apply for an IPO with your minor daughter’s account through the Angel One platform. Alternatively, you can apply through ASBA.

I have submitted my bids for Tarsons Products IPO. When will the funds be debited?

Financial institutions will not deduct the fund as soon as you apply for the Tarsons Products IPO. Banks will simply hold or block the amount. If you receive the allotment, the blocked amount will be deducted. On the contrary, if you are unable to secure share allotments, you will get back the amount before the UPI mandate expires.

How to secure share allotment without fail?

Allotment of IPO is not a guaranteed process. This is because, during the case of oversubscription, share allotment takes place through lottery. Bidders should be aware that Angel One is simply a platform that facilitates the application of IPOs. It has no role in the allotment. To ensure that your application receives successful allotment, you can:

Apply from one Demat account

Apply at the cut-off price

Make sure that your Demat account, UPI ID and bank account are linked with the same pan.

How can I delete or cancel my bid for Tarsons Products IPO?

Here’s how you can cancel or delete your bid for Tarsons Products IPO:

Step 1: Tap on the ‘Investment Opportunities’ option

Step 2: Go to ‘IPOs and FPOs’.

Step 3: Click on ‘Order Book’ and choose the IPO that you wish to cancel or withdraw.

Step 4: Click on ‘Details’ and tap on the ‘Cancel’ option.

Your bid for the said IPO will be withdrawn.

Why did I fail to get an IPO allotment?

Non-allotment: Allotment takes place through a lottery in case of oversubscription.

Rejection: IPO application might be rejected if –

One applies for IPO through various Demat accounts connected with the same PAN card.

The bid price is less than the final issue price.

Demat account, bank account and UPI ID not linked with the one PAN card.

Be a Part of IPO Success Stories!
Join our 2 Cr+ happy customers
+91

4.4 Cr+ DOWNLOADS

Enjoy ₹0 Account Opening Charges

Get the link to download the App

ABOUT US
Trusted by over 2 Cr+ clients, Angel One is one of India’s leading retail full-service broking houses. We offer a wide range of innovative services, including online trading and investing, advisory, margin trading facility, algorithmic trading, smart orders, etc. Our Super App is a powerhouse of cutting-edge tools such as basket orders, GTT orders, SmartAPI, advanced charts and others that help you navigate capital markets like a pro.

COMPANY OVERVIEW
Open Demat Account Brokerage & Other Charges Contact Us In the Media Investor Relations Webinars Careers

INVESTMENT OPTIONS
Stocks Mutual Funds NFO Upcoming IPO Futures Options US Stocks ETF Currencies Commodities NCD Corporate Bonds Tax Free Bonds 54EC bonds Sovereign Gold Bond Tax Saving Bonds

CALCULATORS
Brokerage Calculator Margin Calculator SIP Calculator Lumpsum Calculator CAGR Calculator Dividend Yield Calculator Future Value Calculator Compound Interest Rate Calculator FD Calculator RD Calculator Present Value Calculator EBITDA Calculator Mutual Fund Returns Calculator PPF Calculator EMI Calculator

KNOWLEDGE CENTER
Mutual Funds Demat Account Trading Account Online Share Trading Intraday Trading Share Market IPO Derivatives Commodities Trading Futures and Options Trading Income tax Authorised Person Analyst Corner

LEARN TO EARN
Knowledge Center Smart Money Blog Fundamental Research Technical Research Company Reports Angel One - Community Be Vigilant - Jagruk Tejabhai

BECOME A PARTNER
Become Business Partner Become DRA Who is an Authorised person? Benefits of being an Authorised Person Authorised Person Income Eligibility & Documents Required Authorised Person Business Model Authorised Person App & NXT platform Authorised Person Details Authorised Person Locator

MARKET OUTLOOK
Share Market Announcements Share Market Holidays 2024 Share Market Glossary 52-week High 52-week Low Top Gainers Top Losers

UPCOMING IPO
HDB Financial Services IPO Oyo IPO MobiKwik IPO Fabindia Limited IPO Navi Technologies IPO Byju's IPO

CUSTOMER SUPPORT :
18001020 Support FAQs

FOLLOW US :

FOLLOW US :

OTHER LINKS :
Angel One APP Angel One Trade Angel SpeedPro Margin Trading Facility Smart API Union Budget 2024

PARTNERS :
Sensibull Smallcase Streak Vested TradingView

INDICES :
Nifty 50 Nifty Bank Nifty Financial Services Nifty Next 50 Nifty Midcap 100 BSE Sensex India Vix

STOCKS :
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

US STOCKS :
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Gold Rates :
Gold Rate Today in Mumbai Gold Rate Today in Delhi Gold Rate Today in Chennai Gold Rate Today in Hyderabad Gold Rate Today in Bangalore

Mutual Fund AMCs :
SBI Mutual Funds Axis Mutual Funds HDFC Mutual Funds ICICI Prudential Mutual Funds Nippon India Mutual Funds Kotak Mutual Funds

MUTUAL FUNDS CATEGORIES :
ELSS Funds Liquid Funds Small Cap Funds Arbitrage Funds Gilt Funds Mid Cap Funds Multi Cap Funds Large Cap Funds

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% or "var + elm" whichever is higher as upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

"Prevent Unauthorised transactions in your Trading/Demat Account. Update your mobile numbers/email IDs with your stock brokers/Depository Participant. Receive alerts/information of your transaction/all debit and other important transactions in your Trading/ Demat Account directly from Exchange/CDSL at the end of the day. Issued in the interest of investors."
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
"We understand that certain investment advisors may be approaching members of the public including our clients, representing that they are our partners, or representing that their investment advice is based on our research. Please note that we have not engaged any third parties to render any investment advisory services on our behalf. We do not share our research reports or our clients’ personal or financial data with any third parties and have not authorized any such person to represent us in any manner. Persons making investments on the basis of such advice may lose all or a part of their investments along with the fee paid to such unscrupulous persons. Please be cautious about any phone call that you may receive from persons representing to be such investment advisors, or a part of research firm offering advice on securities. Do not make payments through e-mail links, WhatsApp or SMS. Please do not share your personal or financial information with any person without proper verification. Always trade through a registered broker."
"Issued in public interest by Angel One Limited, having its registered office at 601, 6th Floor, Ackruti Star, Central Road, MIDC, Andheri East, Mumbai - 400093, Telephone: +91 22 4000 3600, Fax: + 91 22 2835 8811."

Disclaimer

Investments in securities market are subject to market risk, read all the related documents carefully before investing.
We collect, retain, and use your contact information for legitimate business purposes only, to contact you and to provide you information & latest updates regarding our products & services.
We do not sell or rent your contact information to third parties.
Please note that by submitting the above-mentioned details, you are authorizing us to Call/SMS you even though you may be registered under DND. We shall Call/SMS you for a period of 12 months.
Angel One Limited, Registered Office: 601, 6th Floor, Ackruti Star, Central Road, MIDC, Andheri East, Mumbai - 400093. Tel: 18001020. CIN: L67120MH1996PLC101709, SEBI Regn. No.: INZ000161534-BSE Cash/F&O/CD (Member ID: 612), NSE Cash/F&O/CD (Member ID: 12798), MSEI Cash/F&O/CD (Member ID: 10500), MCX Commodity Derivatives (Member ID: 12685) and NCDEX Commodity Derivatives (Member ID: 220), CDSL Regn. No.: IN-DP-384-2018, PMS Regn. No.: INP000001546, Research Analyst SEBI Regn. No.: INH000000164, Investment Adviser SEBI Regn. No.: INA000008172, AMFI Regn. No.: ARN-77404, (Date of initial Registration -03-12-2009, Current validity of ARN- 02-12-2026). PFRDA Registration No.19092018.Compliance officer: Mr. Bineet Jha, Tel: 18001020 Email: compliance@angelbroking.com. Only for National Pension Scheme (NPS) related grievances please mail to NPSgrievances@angelbroking.com Grievance Redressal Officer (GRO) - Mr Karan Dalal, Mo. No : 8655719858
For issues related to cyber attacks, call us at +91-8045070444 or email us at cybersecurityissues@angelbroking.com.
For any Law Enforcement Agency notices, please reach out / send notices to legal@angelbroking.com
Brokerage will not exceed the SEBI prescribed limit.

Research Disclaimer Regulatory Content Dos and Don'ts to Safe Investing Scores Dos and Don'ts While Dealing With Investment Advisor FAQs T&C Apply Privacy Policy Digital Lending - Privacy Policy Investor Charter Advisory for Investors NCL Collateral CDSL eVoting NSDL eVoting ODR Portal Risk Disclosure on Derivatives Caution for Investors

Copyright - All rights reserved

Be a Part of IPO Success Stories!
Never Miss IPO Investment
+91

Minimal Brokerage Charges
₹0 brokerage on stock investments and flat ₹0 AMC for first year.
ARQ Prime
Make smart decisions with ARQ prime, a rule based investment engine
Technology Enabled
Trade or invest anywhere, anytime with our App or web platforms

Fast-track your investing journey with Us, India’s fastest growing fintech company

+91

By proceeding, I agree to T&C and Privacy Policy.

Do you already have an account? Login

Open an Account

×

Initializing Search...

Copyright - All rights reserved

We collect, retain, and use your contact information for legitimate business purposes only, to contact you and to provide you information & latest updates regarding our products & services. We do not sell or rent your contact information to third parties.

Please note that by submitting the above mentioned details, you are authorizing us to Call/SMS you even though you may be registered under DND. We shall Call/SMS you for a period of 12 months.
Brokerage will not exceed SEBI prescribed limits
Disclaimer Privacy Policy
Any Grievances related the aforesaid brokerage scheme will not be entertained on exchange platform.